mucos
surfac
common
site
pathogen
colonizationentri
effect
mucos
immun
vaccin
provid
protect
primari
infect
site
aim
develop
new
vaccin
strategi
elicit
mucos
immun
respons
new
strain
enterococcu
faecium
non
pathogen
lactic
acid
bacteria
lab
strong
cell
adhes
abil
identifi
use
vaccin
vector
deliv
two
model
antigen
specif
sigma
c
protein
avian
reoviru
arv
function
homolog
mammalian
reoviru
protein
respons
mcell
target
administ
togeth
subfrag
spike
protein
infecti
bronchiti
viru
ibv
next
effect
immun
rout
immun
respons
assess
deliv
antigen
via
lab
strain
intranas
immun
induc
stronger
humor
respons
intragast
ig
immun
immun
produc
antigen
specif
iga
system
lung
higher
iga
titer
induc
lab
arv
c
protein
attach
moreov
serum
mice
immun
lab
display
dival
antigen
much
stronger
immun
reactiv
arv
c
protein
compar
result
indic
arv
c
protein
deliv
lab
via
rout
elicit
strong
mucos
immun
needlefre
deliveri
approach
conveni
cost
effect
method
vaccin
administr
especi
respiratori
infect
econom
anim
furthermor
arv
c
strong
immunogen
arv
may
abl
serv
immunoenhanc
vaccin
especi
avian
vaccin
mucou
membran
constitut
largest
interfac
bodi
extern
environ
serv
physic
barrier
prevent
entri
dissemin
infecti
pathogen
addit
contain
immunocompet
cell
requir
gener
antigenspecif
mucos
immun
crucial
immunolog
defens
invad
microorgan
microfold
cell
locat
follicleassoci
epithelium
fae
transport
antigen
includ
solubl
protein
infecti
agent
intestin
respiratori
tract
lumen
mucosaassoci
lymphoid
tissu
malt
name
peyer
patch
nasopharynxassoci
lymphoid
tissu
nalt
respect
malt
dendrit
cell
process
present
antigen
cell
turn
preferenti
induc
product
secretori
iga
siga
mucos
surfac
iga
effect
neutral
prevent
attach
intern
pathogen
host
cell
henc
elicit
mucos
immun
critic
develop
vaccin
infecti
pathogen
transmit
mucos
site
vaccin
strategi
target
mucos
immun
mani
advantag
includ
capac
elicit
system
mucos
immun
respons
togeth
improv
access
safeti
costeffect
deliveri
needlefre
sever
line
evid
indic
induct
adequ
mucos
protect
immun
respons
requir
aid
adjuv
present
effect
mucos
adjuv
cholera
toxin
escherichia
coli
lymphotoxin
howev
consid
potenti
toxic
bacteri
toxin
accept
clinic
use
lactic
acid
bacteria
lab
gener
classifi
gra
gener
recogn
safe
organ
tradit
use
food
industri
recent
potenti
applic
lab
vehicl
express
deliveri
model
antigen
mucos
surfac
extens
investig
bermudezhumaran
et
al
show
mice
intranas
administ
lactococci
lacti
antigen
human
papillomaviru
type
anchor
cell
togeth
secretori
form
induc
immun
respons
provid
therapeut
effect
cortesperez
demonstr
simultan
immun
strain
via
intranas
rout
abl
elicit
higher
specif
immun
respons
potent
antitumor
effect
via
intragastr
rout
addit
mohamadzadeh
et
al
report
cocultur
lactobacillu
promot
dc
matur
upregul
express
result
suggest
lab
regul
cell
respons
target
toward
helper
pathway
henc
lab
strain
act
deliveri
vehicl
also
intrins
adjuv
vaccin
nevertheless
effect
lab
immunomodul
may
vari
depend
lab
speci
strain
thu
rout
immun
differ
intrins
adjuvant
lab
strain
need
consid
plan
immun
strategi
addit
lactobacillu
probiot
effect
enterococcu
faecium
e
faecium
demonstr
worthi
note
unlik
lab
enterococcu
genu
consid
gra
safeti
concern
avoid
antibiot
resist
gene
transmiss
casebycas
evalu
pathogen
antibiot
resist
profil
requir
avian
infecti
bronchiti
viru
ibv
member
group
coronavirus
highli
contagi
diseas
chicken
spike
glycoprotein
involv
cell
attach
immunodomin
protein
carri
epitop
produc
virusneutr
antibodi
previous
lee
et
al
found
intranas
oral
immun
mice
lactobacillu
casei
display
spike
protein
sarscoronaviru
surfac
elicit
protect
system
mucos
immun
respons
sar
pseudoviru
base
find
previous
defin
antigen
epitop
spike
protein
ibv
taiwan
local
strain
select
one
model
antigen
use
induct
antigenspecif
antibodi
evalu
current
studi
avian
reovirus
arv
classifi
orthoreoviru
genu
famili
reovirida
sigma
c
protein
compon
outer
capsid
layer
arv
respons
attach
host
cell
membran
induc
high
level
typespecif
neutral
antibodi
structurebas
sequenc
align
arv
sigma
c
mammalian
reoviru
mrv
type
sigma
indic
presenc
heptad
repeat
tripl
alphahel
coiledcoil
structur
ntermin
region
addit
crystallograph
studi
found
carboxytermin
globular
domain
arv
sigma
c
similar
overal
topolog
mrv
type
sigma
shown
mrv
sigma
protein
recogn
receptor
cell
link
sialic
acid
facilit
penetr
antigen
intestin
peyer
patch
mishra
et
al
report
encapsul
hepat
b
surfac
antigen
nanocarri
liposom
mcell
target
ligand
lectin
includ
ulex
europaeu
agglutinin
promot
intestin
uptak
mcell
enhanc
antibodi
product
increas
cellular
immun
respons
immunomodul
arv
sigma
c
yet
report
investig
whether
arv
sigma
c
protein
similar
effect
mrv
sigma
enhanc
mucos
immun
studi
lysm
acma
autolysin
lactococcu
lacti
exogen
bind
peptidoglycan
lab
chosen
anchor
molecul
dock
desir
antigen
protein
onto
lab
surfac
two
model
antigen
ibvspik
arvsigma
c
express
acma
tag
fuse
ctermin
end
display
recombin
protein
lab
surfac
confirm
immun
respons
induc
antigendisplay
lab
evalu
use
anim
model
lactic
acid
bacteria
lab
name
three
enterococcu
faecium
e
faecium
strain
obtain
one
food
industri
research
develop
institut
taiwan
two
isol
pig
intestin
flora
cultur
lactobacilli
mr
broth
difco
tm
detroit
mich
usa
c
without
shake
quantifi
bacteria
e
faecium
grown
logarithm
phase
collect
centrifug
wash
three
time
phosphat
buffer
salin
pb
initi
concentr
bacteria
determin
spectrophotometri
od
nm
number
bacteria
sampl
verifi
pourplat
assay
use
ragosa
agar
plate
difco
tm
detroit
mich
usa
tenfold
serial
dilut
final
lab
dilut
concentr
coloni
form
unit
cfu
ml
escherichia
coli
e
coli
invitrogen
novagen
use
plasmid
amplif
protein
express
respect
grown
lb
medium
shake
c
intestin
cell
line
int
atcc
cultur
use
bme
basal
medium
eagl
earl
bss
fetal
bovin
serum
fb
penicillin
uml
streptomycin
gml
femal
balbc
mice
week
old
purchas
nation
laboratori
anim
center
taiwan
experi
perform
accord
univers
guidelin
gener
recombin
protein
immun
plasmid
express
antigen
protein
fuse
acma
protein
serv
anchor
protein
onto
gram
posit
bacteria
lactic
acid
bacteria
lab
construct
two
step
initi
acma
fragment
obtain
pcr
dna
l
lacti
cremori
use
primer
set
acma
f
cgacaagcttgcacggacggagcttcttc
acma
r
ggtgctcgagtgaaccacctgaatttgta
design
base
sequenc
publish
genbank
access
number
thermal
cycl
condit
c
min
follow
cycl
denatur
c
anneal
c
extens
c
min
finish
final
extens
c
min
pcr
product
expect
size
base
pair
bp
digest
hind
iii
xho
restrict
enzym
subclon
prokaryot
express
vector
result
plasmid
name
base
previou
report
epitop
consist
amino
acid
residu
highli
conserv
subunit
infecti
bronchiti
viru
ibv
spike
protein
show
antibodi
neutral
activ
chosen
use
studi
primer
design
amplifi
subfrag
residu
ibv
strain
genbank
access
number
pcr
primer
sequenc
use
tgctagctagccaatataatactgg
aaaatgtcgacaagctttctgagctg
plasmid
ibvspta
contain
whole
code
region
ibv
use
templat
thermal
cycl
condit
c
min
follow
cycl
denatur
c
anneal
c
min
extens
c
min
end
final
extens
c
min
result
pcr
product
bp
digest
nhe
hind
iii
restrict
enzym
present
primer
fragment
subclon
express
vector
result
plasmid
name
anoth
antigen
protein
full
length
sigma
c
avian
reoviru
arv
amplifi
plasmid
gift
dr
lh
lee
depart
veterinari
medicin
nation
chunghs
univers
access
number
clone
acma
express
vector
pcr
primer
use
arvcf
atagtgtcgacatatggcgggtctc
arvcr
gcgccaaagcttcggtgtcgatgc
amplif
condit
c
min
follow
cycl
denatur
c
anneal
c
extens
c
min
follow
final
extens
c
min
digest
sal
hind
iii
restrict
enzym
pcr
fragment
bp
introduc
vector
result
express
plasmid
design
arvcacma
green
fluoresc
protein
gfp
use
determin
anchor
effici
gfp
code
region
bp
obtain
digest
plasmid
qbiogen
inc
morgan
irvin
ca
usa
nhe
ecor
restrict
enzym
gfp
fragment
introduc
vector
linearl
enzym
express
plasmid
design
authent
pcr
product
confirm
autom
sequenc
clone
initi
check
restrict
enzym
digest
map
structur
variou
plasmid
express
differ
recombin
antigen
protein
present
fig
variou
plasmid
transform
escherichia
coli
strain
recombin
protein
express
induct
mm
iptg
c
h
initi
bacteri
cell
pellet
dissolv
volum
bind
buffer
without
denatur
agent
imidazol
nacl
trishcl
gml
lysozym
follow
freezethaw
cycl
sonic
centrifug
fraction
rpm
min
c
supernat
crude
extract
contain
solubl
gfpacma
obtain
sinc
major
arvcacma
express
insolubl
form
bacteria
pellet
fraction
dissolv
lysi
buffer
imidazol
nacl
trishcl
urea
recombin
protein
express
tag
cterminu
fraction
recombin
protein
purifi
metal
affin
chromatographi
accord
manufactur
protocol
pharmacia
brief
bacteria
crude
extract
load
column
pack
ninta
sepharos
incub
h
room
temperatur
rotat
follow
time
wash
buffer
imidazol
nacl
trishcl
elut
use
buffer
contain
high
concentr
imidazol
mm
stepwis
dialysi
pb
phosphat
nacl
contain
gradual
decreas
concentr
urea
c
remov
imidazol
protein
concentr
determin
bradford
method
biorad
purif
denatur
form
recombin
protein
buffer
contain
urea
contamin
endotoxin
level
recombin
protein
measur
pyrotel
gelclot
endotoxin
test
follow
manufactur
descript
cat
associ
cape
cod
wood
hole
usa
initi
bind
capac
acma
fusion
protein
bacteria
surfac
determin
lab
e
faecium
cfu
incub
differ
concentr
gtube
gfpacma
protein
shake
rpm
c
h
follow
centrifug
min
rpm
subsequ
supernat
bacteria
pellet
fraction
resolv
sdspage
bind
effici
evalu
ratio
acma
fusion
protein
present
supernat
free
form
acma
fusion
protein
bacteria
pellet
anchor
acma
fusion
protein
addit
bacteria
anchor
gfpacma
fusion
protein
directli
observ
fluoresc
microscopi
protein
detach
bacteri
surfac
separ
sdspage
wholecel
elisa
conduct
follow
previou
protocol
briefli
lab
e
faecium
cfu
lab
mix
g
acma
fusion
protein
arvc
l
volum
incub
hour
c
bacteria
wash
three
time
pb
incub
bsa
pb
min
room
temperatur
block
nonspecif
bind
wash
pb
bacteria
pellet
resuspend
l
dilut
primari
antihi
antibodi
solut
abd
serotec
kidlington
uk
incub
h
room
temperatur
bacteria
wash
three
time
pb
incub
secondari
antibodi
horseradish
peroxidas
hrp
conjug
antimous
antibodi
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
dilut
pbst
phosphat
nacl
room
temperatur
h
bacteria
wash
three
time
pb
final
resuspend
l
pb
l
suspens
load
well
elisa
plate
follow
l
abst
substrat
kpl
kirkegaard
perri
laboratori
inc
gaithersburg
md
usa
plate
incub
room
temperatur
min
optic
densiti
nm
measur
protein
resolv
sdspage
electrotransf
nitrocellulos
membran
use
mini
protein
iii
equip
biorad
laboratori
richmond
ca
usa
membran
block
pbst
contain
dri
skim
milk
incub
antihi
tag
antibodi
abd
serotec
kidlington
uk
pbst
overnight
c
sever
time
pbst
buffer
wash
filter
incub
dilut
secondari
antibodi
goat
antimous
igg
conjug
hrp
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
one
hour
room
temperatur
pbst
wash
remov
unbound
antibodi
signal
detect
use
tmb
reagent
kpl
kirkegaard
perri
laboratori
inc
gaithersburg
md
usa
monolay
int
cell
well
cultur
plate
without
antibiot
prior
absorpt
e
faecium
wash
pb
twice
resuspend
bme
medium
concentr
cfuml
subsequ
l
bacteria
ad
cell
monolay
rock
everi
min
h
cell
wash
three
time
pb
fix
formaldehyd
follow
gram
stain
observ
microscopi
one
unit
dose
antigen
anchor
lab
cfu
e
faecium
incub
g
purifi
protein
without
arvcacma
protein
c
h
prior
immun
bind
acma
antigen
fusion
protein
lab
confirm
fraction
centrifug
min
rpm
supernat
contain
unbound
acma
fusion
protein
bacteria
pellet
separ
bind
effici
evalu
sdspage
wholecel
elisa
balbc
mice
age
eight
week
randomli
assign
six
treatment
group
five
mice
group
mice
group
immun
via
intragastr
ig
rout
wherea
mice
group
immun
via
intranas
rout
group
mice
immun
one
three
differ
regimen
lab
without
recombin
protein
lab
anchor
ibv
protein
lab
anchor
ibv
protein
combin
arvcacma
protein
ig
group
mice
immun
unit
antigen
protein
cfu
lab
anchor
g
recombin
protein
l
volum
group
immun
unit
antigen
protein
cfu
lab
anchor
g
recombin
protein
l
volum
group
mice
initi
immun
day
follow
three
booster
twoweek
interv
elimin
influenc
environ
bacteria
immun
respons
deriv
lab
immun
mice
given
drink
water
contain
gentamicin
gml
three
day
immun
throughout
experi
blood
bronchoalveolar
lavag
bal
collect
mous
blood
sampl
obtain
orbit
vascular
plexu
heparin
supplement
centrifug
plasma
transfer
new
tube
store
c
use
bal
sampl
collect
use
modif
method
bergeron
et
al
follow
collect
bal
small
incis
made
trachea
insert
small
tube
connect
syring
lung
wash
perform
inject
ml
pb
lung
follow
aspir
lavag
fluid
bal
fluid
centrifug
rpm
min
supernat
frozen
c
test
antibodi
respons
ibv
epitop
analyz
elisa
nuncimmuno
plate
nunc
coat
recombin
fusion
protein
l
ng
protein
sodium
carbon
buffer
ph
per
well
overnight
incub
c
plate
wash
three
time
pbst
nonspecif
protein
bind
site
block
pbst
buffer
contain
skim
milk
antibodi
detect
plasma
bal
sampl
primari
antibodi
dilut
pb
ratio
respect
goat
antimous
igg
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
iga
sigmaaldrich
inc
saint
loui
mo
usa
conjug
hrp
dilut
use
secondari
antibodi
abt
substrat
kpl
kirkegaard
perri
laboratori
inc
gaithersburg
md
usa
ad
absorb
detect
od
nm
data
express
mean
sem
signific
differ
pinpoint
student
ttest
welch
correct
analysi
varianc
immun
group
antibodi
respons
use
factor
test
statist
signific
effect
oneway
anova
analysi
result
gener
graphpad
statist
packag
analysi
tool
graphpad
softwar
san
diego
ca
develop
lactic
acid
bacteria
lab
vaccin
carrier
acma
protein
use
protein
anchor
display
antigen
surfac
e
faecium
sever
plasmid
construct
produc
chimera
protein
acma
protein
express
ctermin
antigen
protein
first
construct
acma
contain
fragment
bacteri
cell
wallbind
protein
acma
gener
fig
direct
observ
protein
display
lab
microscopi
gfp
code
region
insert
upstream
acma
fig
addit
immunogen
protein
two
avian
virus
use
evalu
possibl
develop
lab
dival
vaccin
carrier
two
pcr
fragment
contain
partial
code
region
viral
envelop
protein
spike
protein
ibv
c
protein
arv
amplifi
pcr
clone
acma
result
plasmid
design
arvcacma
respect
fig
schemat
represent
cisel
structur
plasmid
express
recombin
antigen
illustr
fig
express
recombin
protein
driven
rna
polymeras
iptg
induct
e
coli
strain
construct
success
produc
antigen
protein
variou
level
lane
fig
recombin
protein
purifi
ninta
chromatographi
follow
manufactur
methodolog
pharmacia
ninta
affin
purif
arvcacma
gfpacma
protein
expect
size
kda
kda
kda
respect
obtain
lane
fig
puriti
acma
fusion
protein
analyz
sdspage
lane
fig
ident
initi
confirm
western
blot
fig
three
recombin
acma
fusion
protein
gfpacma
solubl
two
protein
predomin
insolubl
henc
protein
purifi
insolubl
fraction
refold
stepwis
dialysi
pb
remov
urea
one
basic
requir
probiot
strain
capabl
adher
intestin
epitheli
cell
play
part
propag
digest
tract
also
particip
capac
competit
exclus
pathogen
henc
initi
adhes
capabl
new
e
faecium
strain
test
intestin
epitheli
cell
int
subsequ
bind
effici
acma
fusion
protein
onto
surfac
e
faecium
vaccin
carrier
determin
cultur
intestin
cell
line
one
two
new
isol
strain
show
weak
adhes
capabl
fig
sampl
among
three
lab
test
e
faecium
show
greatest
absorpt
capac
fig
use
studi
order
test
bind
capac
recombin
acma
protein
lab
surfac
e
faecium
cfu
incub
differ
amount
gfpacma
fusion
protein
g
h
c
initi
investig
whether
acma
dock
cell
wall
display
antigen
protein
surfac
bacteria
incub
variou
amount
anchor
protein
follow
intens
wash
pb
bacteria
pellet
directli
analyz
fluoresc
microscopi
illustr
fig
lab
bind
assay
higher
amount
gfpacma
use
stronger
intens
gfp
signal
observ
indic
gfp
inde
display
surfac
lab
dose
depend
manner
next
maxim
bind
capac
acma
fusion
protein
lab
investig
analysi
fraction
protein
content
reveal
major
gfpacma
fusion
protein
anchor
e
faecium
fig
notic
unbound
protein
remain
supernat
fraction
g
gfpacma
use
anchor
indic
dose
acma
fusion
protein
exceed
bind
capac
e
faecium
fig
arvcacma
purifi
condit
denatur
remov
dialysi
therefor
worth
check
whether
two
refold
acma
fusion
protein
abl
anchor
onto
lab
whole
cell
elisa
sdspage
employ
confirm
antigen
display
bind
effici
two
recombin
protein
base
bind
capac
result
combin
g
fusion
protein
lab
use
one
unit
immun
dose
coincub
h
follow
intens
wash
pb
e
faecium
bacteria
subject
elisa
detect
antigen
display
strong
reaction
observ
well
contain
bacteria
incub
acma
fusion
protein
whilst
well
untreat
bacteri
cell
remain
neg
fig
centrifug
two
acma
fusion
protein
could
detect
cell
e
faecium
sampl
h
cell
thoroughli
wash
fix
formaldehyd
follow
gram
stain
maximum
bind
capac
acma
fusion
protein
lab
determin
follow
variou
concentr
acma
gfp
fusion
protein
g
indic
sampl
respect
mix
cfu
e
faecium
c
h
follow
intens
wash
pb
centrifug
supernat
contain
unbound
acmagfp
fusion
protein
transfer
new
tube
pellet
contain
lab
anchor
gfp
fusion
protein
directli
examin
fluoresc
microscopi
b
addit
evalu
bind
effici
anchor
form
c
free
form
gfp
fusion
protein
analyz
sdspage
bind
effici
determin
ratio
acma
fusion
protein
present
bacteria
pellet
anchor
form
c
supernat
free
form
pellet
protein
bound
lab
supernat
free
form
protein
fig
result
show
acma
fusion
protein
effect
bind
lab
surfac
next
evalu
whether
immun
cell
surfac
display
recombin
protein
lab
abl
elicit
specif
antibodi
product
mice
induc
mucos
immun
antigenanchor
lab
deliv
intranas
intragastr
ig
rout
immun
protocol
illustr
fig
mice
group
receiv
either
mock
lab
neg
control
lab
display
alon
lab
display
combin
arvcacma
antibodi
induct
serum
sampl
compar
elisa
sinc
acma
anchor
protein
present
antigen
display
lab
poorli
react
test
sera
data
shown
fusion
protein
use
target
protein
evalu
immun
respons
induc
immun
result
show
mice
immun
lab
anchor
combin
without
arvcacma
ig
rout
induc
specif
igg
antibodi
fig
respect
detect
specif
antibodi
observ
sera
collect
anim
receiv
mock
lab
ig
group
day
antibodi
titer
mice
immun
lab
anchor
arvc
significantli
higher
mock
lab
lab
anchor
lab
p
lab
anchor
p
analyz
student
test
fig
group
compar
control
mice
induct
antibodi
mice
immun
lab
display
fusion
protein
alon
signific
signific
increas
antibodi
level
observ
mice
immun
combin
arvc
significantli
higher
lab
p
lab
anchor
p
day
fig
increas
igg
respons
immun
proceed
observ
overal
elisa
result
indic
fusion
protein
anchor
lab
abl
trigger
system
immun
reaction
mice
two
differ
immun
rout
use
final
booster
mice
sacrif
sera
bronchoalveolar
lavag
bal
sampl
collect
allow
detect
antigenspecif
igg
iga
indic
system
mucos
immun
respons
respect
overal
immun
via
ig
rout
gave
much
higher
level
igg
bal
sera
iga
induct
low
fig
c
howev
signific
increas
igg
iga
detect
sera
bal
mice
immun
via
rout
fig
result
suggest
display
recombin
protein
lab
deliv
via
rout
success
abl
elicit
system
mucos
immun
statist
lab
anchor
antigen
without
arvc
deliv
via
rout
induc
stronger
mucos
immun
respons
indic
iga
titer
via
ig
rout
p
analyz
one
way
anova
notic
combin
arvc
fusion
protein
lab
abl
stimul
higher
antibodi
immun
respons
lab
anchor
mock
lab
fig
almost
mice
immun
arvc
produc
higher
iga
titer
mice
immun
two
regimen
mock
lab
alon
p
confirm
accuraci
elisa
result
serum
sampl
test
western
blot
analysi
shown
fig
two
four
sera
mice
treat
lab
anchor
four
five
sera
treat
lab
anchor
two
antigen
arvc
via
ig
rout
recogn
recombin
protein
addit
four
six
sera
mice
treat
lab
anchor
five
six
sera
treat
lab
anchor
two
antigen
via
rout
success
detect
protein
fig
similar
result
elisa
mice
immun
lab
display
two
antigen
immun
via
rout
induc
stronger
antibodi
reaction
via
ig
rout
fig
b
worth
note
sera
sampl
via
rout
fig
detect
specif
antibodi
western
blot
analysi
serum
sampl
mice
immun
via
ig
b
rout
collect
day
antibodi
respons
confirm
western
blot
analysi
fig
compar
analysi
arvc
specif
antibodi
western
blot
serum
sampl
mice
immun
lab
anchor
combin
arvc
antigen
via
ig
b
rout
collect
day
antibodi
specif
two
antigen
detect
western
blot
analysi
strongli
react
arvc
compar
smaller
number
react
strongli
fig
b
stimul
mucos
compart
necessari
optim
protect
antivir
immun
sever
strategi
design
allow
mucos
applic
use
live
attenu
viral
vector
use
adjuv
howev
potenti
side
effect
live
viral
vector
toxic
bioadjuv
great
concern
henc
altern
vaccin
vaccin
strategi
warrant
studi
present
new
vaccin
strategi
show
first
time
avian
reoviru
arv
sigma
c
display
onto
lactic
acid
bacteria
lab
abl
enhanc
system
mucos
immun
avoid
use
gmo
final
applic
control
actual
quantiti
antigen
vaccin
heterolog
protein
express
e
coli
exogen
anchor
lab
surfac
end
autolysin
acma
protein
capabl
dock
cell
wall
gram
posit
bacteria
lab
use
protein
anchor
studi
one
copi
first
lysm
motif
domain
express
allow
fusion
via
ctermin
end
antigen
protein
estim
bind
capac
shown
least
g
acma
fusion
protein
bound
approxim
cfu
e
faecium
higher
previous
report
g
cell
antigen
protein
test
studi
express
recov
insolubl
fraction
high
bind
effici
indic
stepwis
dialysi
abl
restor
conform
acma
protein
great
extent
previous
wu
et
al
report
conjug
mammalian
reoviru
mrv
recombin
protein
dna
vaccin
enhanc
antigenspecif
humor
cellmedi
immun
respons
compar
nake
dna
immun
suggest
sigma
act
cell
ligand
direct
dna
vaccin
nalt
cell
gut
lumen
thu
allow
present
gut
mucos
induct
tissu
turn
induc
mucos
immun
respons
arv
sigma
c
function
homolog
protein
mrv
sigma
crystallograph
studi
partial
arv
sigma
c
show
major
receptorbind
domain
resembl
globular
head
featur
tripl
betabarrel
fibrou
extens
tripl
betaspir
shaft
domain
crystal
structur
arv
sigma
c
mrv
sigma
superimpos
reveal
head
domain
two
protein
share
similar
overal
topolog
loop
connect
also
similar
present
studi
ibv
specif
antibodi
titr
significantli
increas
mice
immun
combin
arv
sigma
c
compar
lab
monoval
conjug
base
structur
similar
reason
suspect
arv
sigma
c
may
possibl
interact
cell
subsequ
enhanc
uptak
present
antigen
effect
cell
lymphoid
induct
tissu
present
cellular
receptor
arv
remain
unclear
associ
sigma
c
cell
prove
current
model
enhanc
ibvspecif
antibodi
lab
anchor
two
antigen
might
result
mcell
target
properti
mediat
arv
sigma
c
gut
loop
assay
result
immunohistochemistri
stain
indic
lab
adher
cell
epithelium
cell
interact
restrict
presenc
sigma
c
lab
without
sigma
c
also
associ
mcell
supplementari
fig
nevertheless
possibl
mcell
target
mediat
sigma
c
examin
describ
previous
arv
sigma
c
anchor
viral
envelop
homotrim
recombin
arv
sigma
c
protein
use
studi
prepar
prokaryot
system
might
gener
protein
proper
conform
henc
defin
mcell
target
properti
eukaryot
express
system
better
option
moreov
also
possibl
arv
sigma
c
enhanc
humor
immun
respons
stimul
cytokin
express
inde
preliminari
data
show
incub
mous
cell
lab
display
arv
sigma
c
significantli
increas
express
alpha
beta
detect
cell
treat
lab
control
supplementari
fig
cytokin
act
adjuv
upregul
humor
cellular
respons
antigen
shown
sever
anim
model
sheep
chicken
addit
shown
contribut
stimul
iga
express
like
enhanc
humer
respons
arv
sigma
c
mous
model
stimul
cytokin
nevertheless
mechan
immunostimul
complic
requir
investig
current
studi
two
model
antigen
avianorigin
virus
use
evalu
whether
new
lab
strain
use
gener
vaccin
carrier
sinc
neither
distribut
function
cell
chicken
report
murin
model
use
altern
nevertheless
broaden
use
lab
strain
anim
speci
test
impact
vaccin
rout
stimul
mucos
immun
antigendisplay
lab
deliveri
system
demonstr
present
studi
other
although
lab
strain
natur
inhabit
intestin
consist
find
sever
report
document
immun
lab
deliveri
system
via
intranas
rout
effect
elicit
high
level
serum
igg
mucos
iga
target
antigen
compar
ig
rout
worth
note
ig
rout
antigen
display
surfac
lab
less
protect
deliv
without
bicarbon
neutral
gastric
acid
circumst
instabl
antigen
might
affect
induct
immun
respons
recent
addit
nalt
kim
et
al
identifi
anoth
type
cell
antigen
uptak
function
name
respiratori
cell
present
singlelay
epithelium
turbin
murin
nasal
caviti
respiratori
cell
abund
nalt
cell
uptak
insolubl
antigen
salmonella
spp
found
much
effici
nalt
suggest
respiratori
cell
play
critic
role
gatewaybarri
upper
airway
furthermor
shown
among
variou
vaccin
rout
nasal
immun
abl
induc
specif
iga
well
system
respons
mediat
antigenspecif
cell
find
support
idea
intranas
immun
promis
avenu
uptak
bacteriadeliv
vaccin
induct
system
mucos
immun
conclus
result
shed
light
potenti
use
e
faecium
deliveri
vehicl
intranas
immun
suggest
arv
sigma
c
consid
safe
effect
immuneenhanc
molecul
adjuv
mucos
immun
includ
avian
vaccin
formul
